Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

SCYNEXIS, Inc. - Common Stock (NQ: SCYX )

1.020 +0.030 (+3.01%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about SCYNEXIS, Inc. - Common Stock

< Previous 1 2 3 4 Next >
SCYX Stock Earnings: SCYNEXIS Misses EPS, Misses Revenue for Q2 2024
SCYX stock results show that SCYNEXIS missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are a hot topic that traders are going to want to know about and we have all of the latest news on Tuesday morning! 
Via InvestorPlace
3 Stocks Under $10 With the Potential for Massive Gains
Discover the growth potential of top small-cap stocks in the consumer finance, healthcare equipment and pharmaceutical industries. 
Via InvestorPlace
3 Dirt-Cheap Drug Developers With Blockbuster Potential
These are three of the best cheap drug developer stocks for investors to keep an eye as their growth could be imminent. 
Via InvestorPlace
7 Undervalued Biotech Stocks to Buy for Big-Time Returns
The broader healthcare sector enjoys a powerfully relevant narrative. Undervalued biotech stocks makes the case even more attractive. 
Via InvestorPlace
Should you consider SCYNEXIS INC (NASDAQ:SCYX) for growth investing?
Exploring SCYNEXIS INC (NASDAQ:SCYX)'s growth characteristics. 
Via Chartmill
SCYNEXIS: Q1 Earnings Insights
Via Benzinga
Looking Into SCYNEXIS's Return On Capital Employed
Via Benzinga
Hidden Gems: 3 Under-$10 Stocks Poised for 500% Growth by 2025
Read here about the top under-$10 growth stocks primed for financial success through strategic partnerships and innovative product offerings. 
Via InvestorPlace
3 Stocks Under $10 With Mammoth Growth Prospects
Learn more about the growth stocks under $10 with progressive fundamentals in the healthcare and technology sectors. 
Via InvestorPlace
SCYX Stock Earnings: SCYNEXIS Beats EPS, Misses Revenue for Q1 2024
SCYX stock results show that SCYNEXIS beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024. 
Via InvestorPlace
SCYX Stock Earnings: SCYNEXIS Misses EPS, Beats Revenue for Q4 2023
SCYX stock results show that SCYNEXIS missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
5 Value Stocks To Watch In The Healthcare Sector
Via Benzinga
A Look Into Healthcare Sector Value Stocks
Via Benzinga
Why Resources Connection Shares Are Trading Higher By Over 6%; Here Are 20 Stocks Moving Premarket
Shares of Resources Connection, Inc. (NASDAQ: RGP) rose sharply in pre-market trading following better-than-expected results for its second quarter. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Gold Moves Lower; TransCode Therapeutics Shares Surge
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher by around 30 points on Monday. The Dow traded down 0.07% to 33,939.93 while the NASDAQ rose 0.24% to... 
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138. 
Via Benzinga
Nasdaq Turns Higher; SCYNEXIS Shares Plunge
U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite trading higher on Monday. The Dow traded down 0.01% to 33,962.53 while the NASDAQ rose 0.26% to 13,246.15. The S&P 500... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Are Antifungal Focused Scynexis Stock Plunging Today?
Scynexis Inc (NASDAQ: SCYX) is voluntarily recalling its antifunga 
Via Benzinga
U.S. Stocks Open Lower; Chicago Fed Index Falls In August
U.S. stocks traded mostly lower this morning, with the Dow Jones trading falling around 80 points on Monday. Following the market opening Monday, the Dow traded down 0.26% to 33,875.83 while the NASDAQ... 
Via Benzinga
Topics Economy Stocks
Exposures Interest Rates US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Want to Get Rich? 3 Game-Changing Penny Stocks to Buy Right Now
While the very concept of penny stocks to buy is treacherous, these analyst-backed ideas could be enticing for the smart speculator. 
Via InvestorPlace
Why DLocal Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
Gainers 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Dow Rises 100 Points; Accelerate Diagnostics Shares Spike Higher
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 100 points on Thursday. The Dow traded up 0.31% to 32,819.16 while the NASDAQ rose 0.63% to 12,001.83. The S&P... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.